Record #66687
Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms
Publisher
Original paper date
Jun 21, 2021
Original DOI
Country
Institution
Department of Lymphatic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022 Zhejiang, China · Cancer Institute (Key Laboratory of Cancer Prevention & Intervention, National Ministry of Education, Provincial Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009 Zhejiang, China
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
4
Same day
1
Post-retraction
0
% post-retraction
0.0%
~1.5 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…